Dr. Reddy's Laboratories (RDY) Launches Authorized Generic Version of Proscar and Zocor
Up)
Dr. Reddy's Laboratories (NYSE: RDY) today announced that it has launched the authorized generic version of Merck's (NYSE: MRK) Proscar tablets 5mg on June 19, 2006. The Company has also launched the authorized generic version of Merck's Zocor tablets 5mg, 10mg, 20mg, 40mg and 80mg on June 23, 2006.
In January 2006, the Company entered into separate agreements with Merck that allowed it to launch the authorized generic versions of Proscar(R) tablets (finasteride) and Zocor(R) tablets (simvastatin). The specific financial terms and conditions of the agreement have not been disclosed.
In January 2006, the Company entered into separate agreements with Merck that allowed it to launch the authorized generic versions of Proscar(R) tablets (finasteride) and Zocor(R) tablets (simvastatin). The specific financial terms and conditions of the agreement have not been disclosed.
You May Also Be Interested In
- Dr. Reddy’s Labs (RDY) Launches Generic OTC Prevacid (NVS)
- Apricus Biosciences (APRI) Granted Request for MycoVa Type C Regulatory Guidance from FDA
- Blood Sugar Basics Game Plan Now Available to Help Patients Tackle Type 2 Diabetes
Create E-mail Alert Related Categories
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
